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Abstract
Plasmodium parasites are the causative agents of malaria, a disease with wide public health
repercussions. Increasing drug resistance and the absence of a vaccine make finding new
chemotherapeutic strategies imperative. Components of the ubiquitin and ubiquitin-like
pathways have garnered increased attention as novel targets given their necessity to para-
site survival. Understanding how these pathways are regulated in Plasmodium and identify-
ing differences to the host is paramount to selectively interfering with parasites. Here, we
focus on Nedd8 modification in Plasmodium falciparum, given its central role to cell division
and DNA repair, processes critical to Plasmodium parasites given their unusual cell cycle
and requirement for refined repair mechanisms. By applying a functional chemical
approach, we show that deNeddylation is controlled by a different set of enzymes in the par-
asite versus the human host. We elucidate the molecular determinants of the unusual dual
ubiquitin/Nedd8 recognition by the essential PfUCH37 enzyme and, through parasite trans-
genics and drug assays, determine that only its ubiquitin activity is critical to parasite sur-
vival. Our experiments reveal interesting evolutionary differences in how neddylation is
controlled in higher versus lower eukaryotes, and highlight the Nedd8 pathway as worthy of
further exploration for therapeutic targeting in antimalarial drug design.
Author summary
Ubiquitin and ubiquitin-like post-translational modifications are evolutionarily conserved
and involved in fundamental cellular processes essential to all eukaryotes. As such, enzy-
matic components of these pathways present attractive targets for therapeutic intervention
for both chronic and communicable diseases. Nedd8 modification of cullin ubiquitin E3
ligases is critical to the viability of eukaryotic organisms and mediates cell cycle progres-
sion and DNA damage repair. Given the complex lifecycle and unusual replication mech-
anisms of the malaria parasite, one would expect neddylation to be of central importance
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to its survival, yet little is known about this pathway in Plasmodium. Here we present our
findings on how Nedd8 removal is controlled in Plasmodium falciparum and how this
pathway differs to that of its human host.
Introduction
The ubiquitin proteasome system is an ancient and highly conserved pathway essential for the
regulation of many important cellular processes in eukaryotes [1]). It is implicated in a great
number of diseases, especially cell cycle disorders such as cancer[2–4]. Therapeutic drugs that
target the ubiquitin proteasome system are, therefore, in demand with Velcade already being
used to treat multiple myeloma patients and several others in clinical trials[5,6]. Ubiquitin is
attached to target proteins via an enzyme cascade consisting of an E1 activating enzyme, an E2
conjugating enzyme and an E3 ligase. The number of ubiquitin moieties and the nature of
their attachment and branching determines the fate and function of the substrate. This process
is reversible and ubiquitin removal is catalyzed by a number of ubiquitin-hydrolases (DUBs).
Other ubiquitin-like post-translational modifiers such as SUMO, Nedd8 and Apg8 are conju-
gated to and released from target proteins following a similar mechanism and using corre-
sponding enzymes.
Infectious pathogens have been found to encode proteins that mimic components of host
ubiquitin (Ub) and ubiquitin-like (UBL) cascades. Expression of Ub and UBL enzymes in
infected cells disrupts these essential pathways in the host, contributing to immune evasion
and manipulation of the cell environment to the pathogen’s advantage[7–9]. Parasitic patho-
gens, being eukaryotic, have a Ub-proteasome system and Ub-like pathways of their own on
which they rely for maintaining homeostasis and survival. Thus, parasite-derived ubiquitin
proteasome components may not only mediate key host-pathogen interactions[10,11] but
present a potentially potent set of novel drug targets for combating parasitic infections[12,13].
The ubiquitin-proteasome system of Plasmodium falciparum has recently garnered
increased attention as a target for therapeutic intervention[14]. However, most examples of
drugs that target the parasite ubiquitin system are proteasome inhibitors[15,16]. Due to the
highly conserved structure of the proteasome, these inhibitors can be non-selective and poten-
tially toxic, although inhibitors with three orders of magnitude preference for the parasite pro-
teasome have been reported[17]. Targeting ubiquitin conjugation and hydrolysis enzymes
presents an alternative and promising opportunity to develop inhibitors with potentially
greater selectivity or wider applicability. Selective targeting of these enzymes is complicated by
their close similarity to host orthologs as is the case with targeting the proteasome. It is there-
fore critical to identify and exploit structural differences between orthologous enzymes as well
as functional differences in how these pathways are regulated differently in parasite and host.
We have previously identified two P. falciparum (Pf) DUBs, UCHL3 and UCH37 (UCH54)
[18,19]. Although P. falciparum and human UCHL3 share the same specificity, structural anal-
ysis revealed distinct differences in the architecture of the active sites that could potentially be
exploited to facilitate selective inhibition of the parasite[20]. We also identified the P. falcipa-
rum ortholog of UCH37 using a similar screening methodology but in this case found two
notable differences in sequence and in specificity. The P. falciparum enzyme has a poly-aspara-
gine insertion in the middle of its sequence, increasing the molecular weight to 54 kDa. Fur-
thermore, by reacting with a panel of activity-based probes, we determined this enzyme to
have dual Ub/Nedd8 specificity unlike the human ortholog that is solely a DUB[19].
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Here we analyze these differences on a molecular basis and elucidate the mechanisms
underlying these enzymes’ Nedd8 activity. Nedd8 hydrolysis in mammals is primarily medi-
ated by the CSN5 metalloprotease subunit of the COP9 signalosome[21], which selectively
deNeddylates cullin E3 ligases. Processing of the Nedd8 precursor and deNeddylation of non-
cullin substrates is mediated by cysteine proteases, including USP21[22], NedP1/Den1/SENP8
[23][24][25], and UCHL3[26]. By sequence homology, Plasmodium parasites appear to lack a
COP9 signalosome and all other known deNeddylases. The one exception is PfUCHL3, an
enzyme whose dual Ub/Nedd8 specificity we have previously described[18,20]. Structural
studies of human UCHL3[27,28] and PfUCHL3[20] have revealed a cross-over loop that effec-
tively blocks access of larger substrates to the enzyme’s active site[29]. As a result, the biological
significance of this enzyme’s activity has been largely assumed to be focused on processing the
C-termini of the Nedd8 and Ub precursor proteins rather than contributing to deconjugation
of these UBLs from larger substrates. Notably for this study, to date, it has not been possible to
uncouple Nedd8 and Ub activities to test their biological relevance separately.
This dearth of predicted deNeddylases suggests that the Nedd8 pathway, despite being evo-
lutionarily highly conserved, may be regulated differently in the malaria parasite versus its
mammalian host with potentially novel enzymes mediating its attachment and removal.
Herein we use functional activity-based probes to screen for deNeddylating enzymes. We elu-
cidate the molecular determinants of PfUCH37 Nedd8 recognition and successfully uncouple
the deNeddylating and deubiquitinating activities of this enzyme. Furthermore, through para-
site transgenics, we show that only the PfUCH37 deubiquitinating activity is essential to the
viability of blood stage P. falciparum parasites.
Results
P. falciparum and mammals have different Nedd8 hydrolase repertoires
We have previously identified two dual activity DUB/deNeddylating enzymes in Plasmodium
falciparum parasites, namely PfUCHL3 and PfUCH37 (also known as PfUCH54)[18,19].
While UCHL3 in both mammals and Plasmodium has dual Ub/Nedd8 activity, no UCH37
enzymes, irrespective of organismal origin, have been reported to have Nedd8 activity, making
PfUCH37 unique.
By sequence homology, there do not appear to be identifiable Plasmodium orthologs to any
classical mammalian deNeddylases which suggests that these parasites have a different reper-
toire of enzymes mediating the Nedd8 pathway.
To capture Plasmodium-specific Nedd8-hydrolysing proteins, we screened P. falciparum
lysate with activity-based electrophilic probes. These types of probes have been widely used to
identify Ub and other UBL hydrolases[19,30,31]. They comprise a C-terminal electrophilic
inhibitor to trap enzymes via their active site cysteine and an N-terminal epitope tag to facili-
tate retrieval and identification[31]. FLAG-Nedd8-VS, based on the human (Hs) Nedd8
sequence, was reacted with P. falciparum lysate and probe-enzyme complexes were captured
by immunoprecipitation on anti-FLAG resin. Enzymes were identified by LC/MS/MS tandem
mass spectrometry, and all protein hits were bioinformatically analysed for presence of defined
ubiquitin and ubiquitin-like hydrolytic domains. Only two enzymes were identified with the
mammalian probe: PfUCHL3 and PfUCH37 (Table 1).
Several key differences between P. falciparum and human Nedd8 made us question whether
this probe was indeed capturing all relevant parasite enzymes. Mammalian and Plasmodium
Nedd8 only share 57% identity (as compared to 99% for ubiquitin) and contain a key differ-
ence within their carboxy-termini. The amino acid in position 72 is a part of the C-terminal
motif of both ubiquitin and Nedd8 (LXLRGG, where X is amino acid 72), which is very
Deneddylation in Plasmodium
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important for the recognition of ubiquitin/Nedd8 by DUBs/deNeddylases and is stabilised by
multiple interactions in the protease active site cleft[32,33]. In ubiquitin, amino acid 72 is an
arginine (R), in human Nedd8—alanine (A), in Plasmodium—glutamine (Q). This variance
results in structural differences that are important for substrate selection. Therefore, we
repeated the initial screen using an activity based probe derived from the sequence of P. falcip-
arum Nedd8, FLAG-PfNedd8-Prg. This probe was prepared using solid phase peptide synthe-
sis in analogy to the DUB specific probe, Ub-Prg[34]. This time four enzymes were captured
including PfUCHL3 and PfUCH37. The putative enzymes were cloned, recombinantly
expressed and their activity was tested in vitro using a fluorogenic assay. UBLs modified C-ter-
minally with amidomethyl-coumarin (AMC) release a fluorescent signal when AMC is cleaved
by a specific protease. Nedd8-AMC, PfNedd8-AMC and Ub-AMC were all screened. Again,
only PfUCH37 (Pf3D7_1117100) and PfUCHL3 (Pf3D7_1460400) were validated as deNeddy-
lases (Table 1) whereas the other two enzymes were determined to have been captured non-
specifically. Pf3D7_0413900 was shown to be a strict DUB. Pf3D7_0726500 could not be
expressed and tested, however the predicted active site residues appear to be split, potentially
only forming a catalytically active enzyme once the protein is folded. We are currently further
characterising this protein. All mass spectrometry data are included in S1 Table.
Multiple sequence alignment reveals clustering of UCH37 orthologs based
on Nedd8 activity
Both PfUCHL3 and PfUCH37 are likely essential to P. falciparum as determined by the
inability to disrupt each gene[20,35]. However, simply knocking out these enzymes would
not distinguish whether their DUB or deNeddylating activities are the indispensable func-
tion. We, therefore, set out to uncouple these activities to see if we could test them sepa-
rately. In order to identify specific differences between single and dual activity UCH
domain enzymes, we extracted all peptidase C12-containing proteins from protein database
Pfam and, using MUSCLE with default parameters[36], aligned them to the UCH37 and
UCHL3 enzymes whose activity we had characterized. Using a representative group of
enzymes, a dendogram of this alignment was generated (Fig 1A). We cloned, expressed and
tested additional orthologs, UBH4 of C. elegans and that of the nematode Trichinella spiralis
(TsUCH37)[37]. Both enzymes were Ub-active but neither was able to hydrolyze
Table 1. DeNeddylating enzymes in Plasmodium falciparum.
Protein name Gene ID HsNedd8-VS FLAG-PfNedd8-Prg_1 FLAG-PfNedd8-Prg_2 Activity
Spectrum count Coverage % Spectrum count Coverage % Spectrum count Coverage %
PfUCHL3
Pf3D7_1460400
1 8.6 5 20.3 0 0 Ub
HsNedd8
PfNedd8
PfUCH37 Pf3D7_1117100 36 34.8 15 17.4 5 9.7 Ub
HsNedd8
PfNedd8
Ubiquitin carboxyl
-terminal hydrolase 13, putative
Pf3D7_0413900 0 0 0 0 4 5.5 Ub
Ubiquitin carboxyl-
terminal hydrolase, putative
Pf3D7_0726500 0 0 1 0.8 4 1.9 Unknown
(did not express)
P. falciparum cell lysate was functionally screened for deNeddylases using FLAG-HsNedd8-VS or FLAG-PfNedd8-Prg, the latter was performed twice
(FLAG-PfNedd8-Prg_1 and FLAG-PfNedd8-Prg_2). Reactions were followed by anti-FLAG immunoprecipitation and proteomic analysis of bound enzymes. Enzymes
were individually expressed in E.coli, purified, and their specificity was validated by reacting with Ub-AMC, HsNedd8-AMC and PfNedd8-AMC.
https://doi.org/10.1371/journal.ppat.1008086.t001
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Nedd8-AMC (S1 Fig). A closer analysis of the alignment revealed patterns of clustering,
with two residues (PfUCH37 N18 and D38) conserved amongst the dual activity enzymes
versus those with DUB activity alone (Fig 1B). Underscoring the potential importance of
these residues to substrate recognition, the crystal structure of the yeast UCH enzyme,
YUH-1 with Ub revealed that D35 (corresponding to D38 of PfUCH37) was central to its
interaction with Ub[38]. Likewise, a model of PfUCHL3 binding to Nedd8 predicts N13 of
PfUCHL3 (N18 of PfUCH37) as being key to their interaction[20].
Fig 1. Phylogenetic analysis of UCH37 sequences reveals clustering based on Nedd8 activity. A) A dendrogram showing the
relative similarity of selected UCH37 enzyme sequences. UCHL3 enzymes with known Nedd8 and Ub specificity are also included for
reference. All enzymes with experimentally confirmed Nedd8 activity are colored, with Nedd8-active enzymes highlighted in red and
inactive ones in blue. B) A multiple alignment of all highlighted enzymes reveals 2 residues (marked with red arrows) whose identity
segregates based on Nedd8 activity.
https://doi.org/10.1371/journal.ppat.1008086.g001
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Removal of the PfUCH37 poly-asparagine repeat does not inhibit activity
A comparison of human and P. falciparum UCH37 reveals a low complexity poly-asparagine
insertion in the parasite protein that increases its molecular weight to 54kDa (hence we previ-
ously referred to it as PfUCH54)[19] (S2A Fig). Poly-asparagine repeats are commonly found
in the Plasmodium genome, but no specific function has been attributed to them on a tran-
scriptional or a translational level[39]. Previous studies have demonstrated the dispensability
of poly-asparagine repeats to protein function[40], and we hypothesized that the same would
be the case with PfUCH37. Indeed, deletion of the asparagine-rich stretch (depicted in red)
does not affect folding of the catalytic domain nor does it appear to negatively impact enzyme
activity against either Ub-AMC or Nedd8-AMC. In fact, the mutant enzyme seemed to be
even better at hydrolyzing Nedd8 (S2B Fig). It is possible that the deletion of the poly-aspara-
gine domain may alter some protein dynamics such that Nedd8 binding/release is more effi-
cient. As Nedd8 and Ub have a different surface charge distribution, it could be that the
asparagines may interact differently with the two UBLs. However, given that the poly-aspara-
gine domain is unstructured, it is difficult to draw any definitive conclusions. Since we were
interested in understanding the molecular basis of this enzyme’s Nedd8 activity, we decided to
make use of the deltaN (dN) mutant given its exaggerated phenotype. Thus, any further men-
tion of PfUCH37 in in vitro assays refers to the poly-asparagine deletion mutant.
Ub and Nedd8 activity of PfUCH37 can be uncoupled
We hypothesized that mutating one or both of the highlighted residues in PfUCHL3 (N13D,
D33E) and PfUCH37 (N18D, D38E) would abolish Nedd8 activity and that the converse muta-
tions in the human enzyme, HsUCH37 (D12N, E33D), would bring about a gain in deNeddy-
lating activity. Using site-directed mutagenesis we introduced these changes, recombinantly
expressed the mutant enzymes and tested their specificity against Ub- and Nedd8-AMC.
The D33E mutation in PfUCHL3 had a mildly inhibitory effect on both Ub-AMC and
PfNedd8-AMC processing (S3 Fig). From our previous structural modeling of the
PfUCHL3-PfNedd8 complex[20], N13 appeared to have a more central role in stabilising the
interaction. However, mutation of N13 to D made the enzyme slightly more active against
both Ub- and Nedd8-AMC (S3 Fig). Notably, neither mutation on it own nor both together
affected either Ub or Nedd8 hydrolysis selectively. We performed extensive in silico modeling
whereby the predicted binding affinity of PfUCHL3 to Ub and Nedd8 was assessed for every
possible substitution of each amino acid at the interacting interface. Aside from the N13D
mutation already tested in vitro, this analysis did not reveal any further residues expected to
differentially affect the enzyme’s Nedd8 and Ub activities (S2 and S3 Tables).
Likewise, the corresponding PfUCH37 N18D mutation left the Ub and Nedd8 activities of
the enzyme largely unaffected (S4 Fig). This mutation was not predicted to alter interactions
within the structures of the complexes, nor was it predicted to alter the affinity of the com-
plexes by the protein-protein interaction analysis tool, mCSM-PPI[41].
However, when we replaced the PfUCH37 D38 with E, we saw a striking effect, namely the
near elimination of Nedd8 activity while hydrolysis of Ub-AMC remained unaffected (Fig 2A
and 2B). Notably, the reverse mutation in the human UCH37 turned the enzyme into one
whose Ub proteolysis is significantly decreased and Nedd8 proteolysis is dramatically
increased, resulting in a mutant with both functions (Fig 2C and 2D). We confirmed this phe-
nomenon by introducing the corresponding mutation in TsUCH37 (E32D) and testing its
Nedd8 activity with similar results (S1D Fig). Thus, the substitution of a single amino acid suc-
ceeded in uncoupling the Ub and Nedd8 specificity of these enzymes.
Deneddylation in Plasmodium
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In order to understand the conformational change a D versus an E might impart on the
overall protein as well as its interaction with UBLs, we generated structural models of wild
type and mutant PfUCH37 and HsUCH37 in complex with both Nedd8 and ubiquitin using
the experimental crystal structures of related UCH37 enzymes (Fig 3).
In the structures of PfUCH37 and HsUCH37, D38 and E34, respectively, are located in a
groove at the Ub/Nedd8 binding interface, making strong inter-molecular interactions that
drive binding affinity and specificity to Ub and Nedd8 (Fig 3). These residues are located near
residue 72 of ubiquitin (R72) and Nedd8 (A72), key residues that have been previously shown
to modulate E1 selectivity specificity[33]. Binding to this region stabilizes the enzyme-sub-
strate complex and positions the cleavage site relative to the catalytic site of UCH37. Within
PfUCH37, the mutation D38E would recreate the formation of the hydrogen bonds to R72 in
ubiquitin seen in the crystal structure of the complex with HsUCH37. By contrast, the
Fig 2. Ubiquitin and Nedd8 enzyme activity can be uncoupled. Enzymatic activity of PfUCH37 and HsUCH37 wild type and mutant enzymes was tested by Ub-AMC
and Nedd8-AMC hydrolysis. A Ub-AMC assay was done using recombinant A) PfUCH37 dN and a D38E mutant or C) HsUCH37 and its E34D mutant. 10nM of enzyme
was incubated with an excess of Ub-AMC (250 nM) and hydrolysis was measured in relative fluorescence units. PfNedd8-AMC hydrolysis by B) PfUCH37 dN and its
D38E mutant or D) HsUCH37 and its E34D mutant, was measured using 250nM of recombinant protein incubated with 500 nM of PfNedd8-AMC. Cleavage was
measured by fluorescence output every 15 seconds for a minimum of 30 minutes and as a negative control, enzymes were pre-incubated with NEM for 15 minutes prior to
being used in the assays. Error bars correspond to standard deviation from triplicate repeats.
https://doi.org/10.1371/journal.ppat.1008086.g002
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extension of the carboxylic acid moiety of the glutamic acid into the binding pocket would
alter this interaction with the distal Nedd8, such that the stabilised conformation no longer
promotes the exo-specific cleavage of Nedd8 by UCH37. This was consistent with the
mCSM-PPI predictions that indicated that mutation of D38E in PfUCH37 would slightly
improve binding to ubiquitin, but significantly destabilise binding to Nedd8.
In HsUCH37, E34 is positioned to make key hydrogen bonds to R72 of ubiquitin. Upon
mutation to D, these interactions would be lost; however, additional interactions to D12 and
Y262 of ubiquitin could be formed without altering the orientation of the stabilised distal ubi-
quitin. By contrast, this E34D mutation would open up the binding pocket to allow binding of
Fig 3. Structural models showing the effects of the mutations on the ubiquitin and Nedd8 binding pocket of UCH37 enzymes. Ribbon
representations of PfUCH37 (light grey) and HsUCH37 (dark grey) in complex with A) and C) human ubiquitin (cyan) and B) and D)
HsNedd8 (green). The wild type UCH37 residues are shown in orange, and the mutant in magenta. Polar interactions are shown in orange,
hydrogen bonds in red and hydrophobic interactions in green.
https://doi.org/10.1371/journal.ppat.1008086.g003
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Nedd8. This was consistent with the mCSM-PPI predictions that E34D would improve bind-
ing to Nedd8 but have minimal effect on ubiquitin recognition.
PfUCH37 Nedd8 activity is dispensable to parasite viability
In mice, disruption of UCH37 is embryonic lethal[42]. Assuming evolutionary conservation,
one would expect its ubiquitin activity to be central to parasite survival as well. Indeed, in a
large-scale insertion mutagenesis screen in P. falciparum, no insertions were observed in
PfUCH37, suggesting essentiality[35]. Similar genetic studies in the mouse malaria parasite, P.
berghei, suggest that parasite growth is significantly impaired in its absence[43]. However,
functional disruption does not address whether the Ub or Nedd8 activity is responsible for this
phenotype. Considering the absence of other classical deNeddylases, we hypothesized that
PfUCH37 should regulate deNeddylation in P. falciparum and that this activity should be
essential. With our newfound ability to uncouple the two activities, we used CRISPR/Cas9 to
edit the endogenous gene to introduce the D38E mutation. As a control, a second parasite line
was generated for which only silent mutations were introduced (D38D). Clonal lines were iso-
lated by limiting dilution, and were used to examine the phenotypic effects on parasite growth,
as well as sensitivity to cell stress induced by the antimalarials dihydroartemisinin (DHA),
chloroquine and methylene blue. Contrary to our expectation, the mutant parasites grew nor-
mally (Fig 4). When comparing the D38E to the D38D lines over the course of 8 days, the
D38E parasites appeared to have accelerated growth at higher parasitemias (Fig 4A). However,
when each mutant line was subjected to a head-to-head competition assay against a GFP refer-
ence line, there was no significant difference in their rates of growth (Fig 4B). Furthermore,
the D38E parasites did not display increased sensitivity to drug treatment (Fig 5A–5C). When
treated with the human Nedd8 E1 inhibitor, MLN4924, both mutant and wild type parasites
succumbed equally at 10μM concentrations and above (Fig 5D). This result further under-
scores the irrelevance of PfUCH37 Nedd8 activity to parasite viability, however it also indicates
that a functional Nedd8 pathway is essential.
There is precedent in the literature for disruption of deNeddylation having no overt pheno-
type: Nedd8 is essential to S. pombe fission yeast, however simultaneous knockout of all
enzymes with Nedd8-hydrolysing activity does not affect growth and viability[44]. Although
deletion of NedP1 in the mammalian system is also not lethal, NedP1 -/- cells are reported to
have altered responses to oxidative stress[45,46]. However, since artemisinin is known to affect
parasites through induction of oxidative stress and since we saw no change in sensitivity to
DHA, this mechanisms is unlikely to occur in the PfUCH37 D38E line.
Plasmodium UCHL3 cannot deNeddylate Cullin-1
Given that we only found two deNeddylases in our screen and determined the activity of
PfUCH37 to be non-essential, we wondered if PfUCHL3 is, in fact, capable of mediating
Nedd8 removal from protein substrates. Although our previous data would lead us to expect
that the deNeddylating activity of PfUCHL3 is limited to processing the Nedd8 precursor pro-
tein, it has more recently been shown that mammalian UCH family enzymes are indeed capa-
ble of processing Ub attached to larger proteins as long as the protein in question is not
another Ub[47]. These data would suggest that the inability of UCHL3 to process polyUb
chains is not a result of steric hindrance to its active site, but rather something to do with the
chemistry of the Ub-Ub interaction. Given this enzyme’s high affinity to human Nedd8-AMC,
we tested whether it would be capable of deNeddylating an active (neddylated) Cullin-1 RING
E3 ligase complex immunoprecipitated out of HEK293T cells (S5A Fig). Both the neddylated
and unneddylated forms of Cullin-1 were detectable by blot. Immunoprecipitated protein was
Deneddylation in Plasmodium
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treated with purified PfUCHL3, PfUCH37dN or human COP9 signalosome as a positive con-
trol, separated on SDS-PAGE and probed with an anti-Cullin-1 antibody to assess presence or
absence of the neddylated form. Despite being capable of hydrolysing human Nedd8-AMC,
neither PfUCHL3 nor PfUCH37dN demonstrated activity against neddylated human Cullin-1
Fig 4. D38E mutation in PfUCH37 does not affect parasite fitness. P. falciparum Dd2 parasites were edited using CRISPR/Cas9 to
generate PfUCH37 D38E mutants or PfUCH37 D38D silent mutants as controls. A) Parasite growth was assessed over the course of 8
days, with parasitemia recorded on a daily basis for both parasite lines. B) A head-to-head competition assay was done to measure growth
of each mutant line against the Kar2_GFP reference line over the course of 8 days. Data points are expressed as ratios (D38E:GFP and
D38D:GFP). Error bars correspond to standard deviation from triplicate repeats.
https://doi.org/10.1371/journal.ppat.1008086.g004
Deneddylation in Plasmodium
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(S5B Fig). Given the mixture of parasite enzymes and human Cullin-1, we still cannot exclude
the possibility that these P. falciparum enzymes might be active against physiological
PfNedd8-modified substrates. Once neddylated substrates are identified in vivo, we will be
able to definitively assess this point.
Discussion
Protein neddylation is an essential process in a wide range of organisms including mammals
[48], plants[49], lower eukaryotes[50,51] and yeast[52]. Although a comprehensive functional
analysis of this pathway in parasitic systems is ongoing, orthologs of Nedd8, the E1, E2 and E3
enzymes involved in its conjugation, and its best-defined substrate, the cullin E3 ligases, can all
be identified in these organisms [12,53]. In P. falciparum, the presence of putative Nedd8, the
catalytic subunit of the Nedd8 E1 (UBA3) and the Nedd8 E2 (UBC12) ligases suggests that this
pathway is indeed functional. Moreover, UBA3 and UBC12 are both nonmutable genes[35],
indicating that neddylation is an essential process. The absence of NedP1, USP21 and the
COP9 signalosome, inclusive of the CSN5 metalloprotease subunit, suggests alternate mecha-
nisms of deNeddylation control in these parasites. Screening P. falciparum lysate with Nedd8
Fig 5. PfUCH37 D38E mutants and wild type parasites respond similarly to drug challenge. PfUCH37 D38E mutants, D38D controls and the Dd2 wild type parent
line were treated for 72-h with a 2-fold serial dilution of A) dihydroartemisinin (from 50 nM to 0.1 nM), B) chloroquine (10 μM to 0.02 μM), C) methylene blue (100 nM
to 0.2 nM) or D) MLN4924 (200 μM to 0.391 μM) and parasite growth measured by SYBR green assay. In panel D, the dotted line corresponds to the equivalent
concentration of DMSO, which at the highest concentration used (1% v/v) has an impact on parasite growth. Data reported as means ± standard errors with n� 3.
https://doi.org/10.1371/journal.ppat.1008086.g005
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activity-based probes identified only two potential candidates: PfUCHL3 and PfUCH37 ubi-
quitin hydrolases, both likely essential enzymes[20][35]. UCH enzymes are characterized by
an active site cross-over loop. UCHL3 has a tighter, more restrictive loop[27] that extends
across the C-terminal residue of the Ub moiety when bound[28,38]. This conformation
requires that substrates be of sufficiently small size to pass through[29] or that bonds to be
hydrolysed have specific characteristics[47]. As a result, the physiological functions of UCHL3
are assumed to be centered around processing Ub and possibly Nedd8 precursors. The cross-
over loop of UCH37, however, is expanded and capable of accommodating larger substrates
including ubiquitin chains, particularly when its C-terminal tail extension is bound by the pro-
teasome (or other physiological partners) and catalytic activity is maximized[54]. We would
expect that in the presence of a physiological substrate that binds its C-terminal tail, the effi-
ciency of PfUCH37 Nedd8 deconjugation would be even more appreciable than what we
observed in vitro. Therefore, it is conceivable that PfUCH37 can deNeddylate substrates nor-
mally relegated to NedP1 control[25,33].
By successfully uncoupling the Ub and Nedd8 activity, we were able to demonstrate that
PfUCH37-mediated deNeddylation is dispensable, at least as pertains to the asexual blood-
stage. It will be interesting to assess whether these mutant parasites are disadvantaged at other
developmental stages or more susceptible to certain stress stimuli. Experiments are underway
to test these possibilities. Why Plasmodium would retain an enzyme with a seemingly irrele-
vant specificity is puzzling. Furthermore, how its Nedd8 hydrolysis is regulated, be it by locali-
zation, protein interactions or other means is also of interest.
Although we were unable to uncouple Nedd8 and Ub activities of PfUCHL3, we are
inclined to believe that this enzyme is unlikely to be the main deNeddylase in Plasmodium par-
asites given its inability to process neddylated Cullin-1. The absence of other deNeddylases in
our screen begs the questions of how the Nedd8 pathway is controlled in parasites, which pro-
teins are the target substrates and whether Nedd8 hydrolysis is even essential. Considering the
probes we used in our screens are specific to cysteine proteases and that Cullins are exclusively
deNeddylated by the CSN5 metalloprotease subunit of the COP9 signalosome (absent in P. fal-
ciparum), it is possible that an unidentified, parasite-specific metalloprotease is fulfilling this
function. However, searching PlasmoDB for the InterPro (www.ebi.ac.uk/interpro/) domain
IPR000555 (JAB1/MPN/MOV34 metalloenzyme domain) returns only three proteins in the P.
falciparum proteome. Two of them are the orthologs of the proteasome subunits Rpn11 and
Rpn8, while the third one is a putative eukaryotic translation initiation factor 3 subunit f
(eIF3f). Although PfRpn11 contains an active MPN+ domain, PfRpn8 and PfeIF3f have inac-
tive MPN- domains that lack the essential catalytic residues.
Taking the D/E dichotomy as predictive of Nedd8 specificity, an alignment of all members
of the peptidase C12 family (including all UCHL3 and UCHL5/37 enzymes) identifies mostly
budding yeast and fungi as having a dual specificity UCH enzyme. This is not surprising since,
like S. cerevisiae Yuh-1, these organisms possess a single UCH enzyme. However, two non-
plasmodial parasites are predicted to have a dual activity UCH37: the Chinese liver fluke, Clo-
norchis sinensis and all species of the Leishmania genus. Notably, C. sinensis also has an ortho-
log of NedP1 whereas the Leishmania species do not. Given the recent sequencing of many
parasitic and metazoan genomes, it will be interesting to perform a more detailed analysis
across eukaryotes to assess whether UCH37 dual specificity and NedP1 presence are somehow
functionally linked and to assess whether additional factors might influence the behavior of
this enzyme in vivo.
In conclusion, our findings raise interesting points regarding the evolution of neddylation,
highlighting differences within this essential pathway between P. falciparum and the human
host. We are currently working towards fully characterising this pathway in the parasite to
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determine whether these differences can be targeted for the development of novel therapeutics
against malaria.
Materials and methods
Cloning, mutagenesis and protein expression
PfUCH37 (PfUCH54) and PfUCHL3 were previously cloned into a bacterial expression vector
pET28a+[19][20]. Other UCH enzymes were amplified from cDNA or genomic DNA of
respective organism and cloned into pet28a+. PfUCH37dN was created by removal of the
poly-asparagine (polyN) domain (amino acids 251–298 of PfUCHL3) using PCR-mediated
deletion. Site-directed mutagenesis to generate PfUCH37 D38E, HsUCH37 E34D, TsUCH37
E32D, PfUCHL3 N13D, PfUCHL3 D33E, and PfUCHL3 N13D D33E was done using the Agi-
lent Site-Directed Mutagenesis Kit following manufacturer’s specifications. BL21-CodonPlus
(DE3)-RIL E. coli (Agilent) were used for protein expression. Bacterial cultures were grown at
37˚C, and protein expression was induced with 0.1 mM IPTG at OD600 of 0.6 for 18 hours at
18˚C. Soluble proteins were purified via their 6HIS tag on NiNTA resin (Qiagen) following
manufacturer’s specifications.
Probe generation and screening
Plasmodium falciparum 3D7 parasites were cultured as previously described[55]. Schizont cell
pellets were lysed in lysis buffer (50 mM Tris, 150 mM NaCl, 1% Triton X-100, 5mM L-cyste-
ine) on ice and centrifuged at 13.3 krpm for 15 minutes. 1mM FLAG-NEDD8-VS (BostonBio-
chem) or FLAG-PfNedd8-Prg (prepared using solid phase peptide synthesis as described in
Ekkebus et al.[34]) was added to the cell lysate supernatants and incubated for 90 minutes at
37˚C. FLAG fusion proteins were then immunoprecipitated using Anti-FLAG M2 Affinity Gel
(Sigma-Aldrich) and eluted using 3X FLAG peptide (Sigma-Aldrich) according to the manu-
facturer’s instructions. NuPAGE 4–12% Bis-Tris gels were used for SDS-PAGE of the eluates,
followed by staining with Coomassie Blue.
Mass spectrometry analysis
1D gel bands were excised and transferred into a 96-well PCR plate. The gel bands were cut
into 1mm2 pieces, destained, reduced (DTT) and alkylated (iodoacetamide) and subjected to
enzymatic digestion with trypsin overnight at 37˚C. After digestion, the supernatant was
pipetted into a sample vial and loaded into an autosampler for automated LC-MS/MS analysis.
LC-MS/MS experiments were either performed using a Dionex Ultimate 3000 RSLC
nanoUPLC (Thermo Fisher Scientific Inc, Waltham, MA, USA) system coupled with an Orbi-
trap Lumos mass spectrometer (Thermo Fisher Scientific Inc, Waltham, MA, USA) or a
nanoAcquity UPLC (Waters Corp., Milford, MA) system coupled to an LTQ Orbitrap Velos
mass spectrometer (Thermo Scientific, Waltham, MA). In both cases, separation of peptides
was performed using C18 reverse-phase chromatography at a flow rate of 300 nL/min and a
total LC run time of 60 minutes. In each case, CID MS/MS spectra of eluting peptides were col-
lected automatically by means of linear ion trap mass analysers.
Post-run, all MS/MS data were converted to mgf files and the files were then submitted to
the Mascot search algorithm (Matrix Science, London UK) and searched against the Uniprot
Plasmodium falciparum database (UP000001450) and a common contaminant sequences con-
taining non-specific proteins such as keratins and trypsin (115 sequences, 38274 residues).
Variable modifications of oxidation (M) and deamidation (NQ) were applied as well a fixed
modification of carbamidomethyl (C). The peptide and fragment mass tolerances were set to
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25ppm and 0.8 Da, respectively. A significance threshold value of p<0.05 and a peptide cut-off
score of 20 were also applied. All data was then imported into the Scaffold program (Ver-
sion_4.5.4, Proteome Software Inc, Portland, OR).
AMC assays
Proteins were used in Ub-AMC and Nedd-AMC (Boston Biochem) assays as previously
described[56]. Briefly, enzyme concentrations were adjusted using BCA assay (Pierce), and
reactions were initiated by addition of Ub- or Nedd8-AMC substrate at the indicated concen-
trations. Fluorescence was measured in relative fluorescence units (RFU) on a BMG FLUOstar
Omega plate reader.
Parasite mutagenesis by CRISPR/Cas9 editing
Mutant PfUCH37-D38E and silent control PfUCH37-D38D parasites were generated using
CRISPR/Cas9. A guide RNA (TATGATATGCTTAAACGTAT) targeting a site in PfUCH37
25 bp upstream of the D38 codon was designed using Benchling (https://benchling.com/).
Complementary oligos encoding the gRNA sequence (tattTATGATATGCTTAAACGTAT /
aaacATACGTTTAAGCATATCATA) were phosphorylated using T4 polynucleotide kinase
(5U for 30 min at 37˚C) and annealed (95˚C for 5 min, followed by step down of 5˚C/min to
25˚C). The oligo mixture was diluted 1/200 in water and ligated into the BbsI-digested
pDC2-coCas9-U6.2-hDHFR plasmid[57]. Donor templates (390 bp in length, starting 76 bp
upstream of the UCH37 coding sequence) were synthesized as GeneStrings by ThermoFisher
and inserted into the AatII/EcoRI sites of the pDC2-coCas9-U6.2-hDHFR plasmid by Gibson
assembly, to generate the final transfection vectors, pDC2-coCas9-UCH37-D38E-gRNA-
hDHFR and pDC2-coCas9-UCH37-D38D-gRNA-hDHFR.
Ring-stage parasites (Dd2) at 5% parasitemia were transfected by electroporation with a
BioRad Gene Pulser II at 310V and 950μF with 50μg of each plasmid DNA. Transformed para-
sites were then selected for 10 days with 2.5 nM WR99210 (Jacobus Pharmaceuticals), followed
by culturing in complete media without drug selection. Edited clones were then isolated by
serial limiting dilution and confirmed by Sanger sequencing after PCR amplification from
genomic DNA using forward primer 5’ CCTTGCGAAAAAATGTATTATTTCA and reverse
primer 5’ GGAAACAAAATGAAAGGAGTCT.
Parasite growth and drug sensitivity assays
Dd2 parasites were propagated as previously described[55] in RPMI-1640 with 50 mg/l hypo-
xanthine, 0.25% sodium bicarbonate, 0.5% Albumax II and 25 mM HEPES (Life Technologies)
and supplemented with GlutaMAX at 1x concentration (Gibco). To evaluate the fitness of the
PfUCH37-modified parasites, we measured parasite growth using two different methods.
Overall growth of the PfUCH37-D38E and D38D control lines was measured by flow cytome-
try (Beckman Coulter Cytoflex) on a daily basis, with an initial starting parasitemia of 0.5%.
Upon crossing the 5% parasitemia threshold, parasitemia was restored to 0.5% to prevent over-
growth and stress. A second method to assess relative growth rates was performed by a com-
petitive growth assay with a fluorescent reference line[58]. Test parasites (either
PfUCH37-D38E or PfUCH37-D38D) were mixed in a 1:1 ratio with the fluorescent reference
line, Dd2-GFP, in which an integrated eGFP reporter was expressed from the strong ER hsp70
(PF3D7_0917900) promoter. At regular intervals an aliquot of each culture was first stained
with Mitotracker Far Red, and the ratio of the GFP-negative test line to the GFP-positive refer-
ence was measured by flow cytometry. Note that due to slower growth of the reference line
due to high levels of GFP overexpression, the test lines eventually overgrow the reference line.
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To assess their effect on PfUCH37-modified parasites, a two-fold serial dilution of each com-
pound (MLN4924, Bio-Techne; dihydroartemisinin, Cambridge Bioscience; chloroquine and
methylene blue, Sigma-Aldrich) was performed in technical duplicate using 96-well flat bottom
plates. Parasites at predominantly ring-stage were added at 1% parasitemia (1% final haemato-
crit). Plates were incubated at 37˚C for 72 hours and parasite growth measured using SYBR
green I stain (Life Technologies) prepared in lysis buffer (final concentration 1x SYBR green I
stain in 5 mM Tris-HCl, 1.5 mM EDTA, 0.05% w/v saponin, 0.5% v/v Triton X-100), incubated
at 37˚C for 30 minutes, and fluorescence signal measured on a FLUOstar Omega (BMG Bio-
tech). At least three independent experiments were performed to test parasite drug sensitivity.
Purification of SCFFbxl17 complexes and in vitro deNeddylation
HEK293T cells (ATCC) were transfected with SCF components (Skp1, Cul1, Myc-Rbx1) and
FLAG-Fbxl17. After 48 hours, cells were resuspended in lysis buffer (LB) (25 mM Tris-HCl,
pH 7.5, 225 mM KCl, 1% NP-40) with a protease inhibitor cocktail (Sigma-Aldrich) and phos-
phatase inhibitors (10 mM NaF, 1 mM PMSF, 1mM Na3VO4). Lysates were incubated with
Anti-FLAG M2 Affinity Gel (Sigma-Aldrich) for 5 hours at 4˚C with rotation. Beads were
washed in LB and eluted in 300 μg/mL FLAG peptide (Sigma-Aldrich) in elution buffer (10
mM HEPES, pH 7.9, 225 mM KCl, 1.5 mM MgCl2, 0.1% NP-40) for 1hr at 4˚C with rotation.
Purified 500nM SCF complex (wt) was incubated with 100nM PfUCHL3, PfUCH37dN or
human COP9 signalosome (Enzo, BML-PW9425) for 2.5 hours at 37˚C (in 25mM Tris pH7.4,
100mM NaCl, 1mM DTT and 5% glycerol), followed by SDS-PAGE and Western blots. Anti-
Cullin-1 (abcam, ab75812, 1:1000), anti-Nedd8 (GeneTex, GTX61205, 1:1000) Anti-Skp1 (BD
Biosciences, 610530, 1:1000), anti-myc-tag (Rbx1), anti-myc (Cell Signalling, 2272, 1:1000),
anti-polyhistidine (Sigma, H1029, 1:2000) and anti-CSN5/JAB1 (Novus Biologicals, 2A10,
1:1000) primary antibodies were used for Western blots.
Structural modeling
Molecular models were generated using Modeller[59] and MacroModel (Schrodinger, New
York, NY). PfUCH37 was modelled using an ensemble of available UCH37 X-ray crystal struc-
tures (PDB IDs: 3A7S and 3IHR, 44% and 36% sequence identity respectively), including the
complex of TsUCH37 with ubiquitin (37% sequence identity; PDB ID: 4IG7). The structures
of PfUCH37 and TsUCH37 (PDB ID: 4IG7) were minimized using the MMF94s forcefield in
Sybyl-X 2.1.1 (Certara L.P., St Louis, MO), with the final structure having more than 95% of
residues in the allowed region of a Ramachandran plot. Ubiquitin and Nedd8 were docked
into the structures of UCH37 using Piper (Schrodinger, New York, NY), with the available X-
ray crystal structure of TsUCH37 in complex with ubiquitin (PDB ID: 4IG7) used to guide
protein docking. The models of the complexes were minimised using the MMF94s forcefield
in Sybyl-X 2.1.1 as described above. The quality of all the models were confirmed with Veri-
fy3D[60]. The structural consequences of the differences in interfacial residues were analysed
to assess the structural importance of the residues[41,61–63]. Interactions were calculated
using Arpeggio[64] and model structures were examined using Pymol.
Supporting information
S1 Table. Mass spectrometry data for activity-based probe pulldowns. Table summarizing
the results of the three pulldown experiments performed (PfNedd8-Prg twice and
HsNedd8-VS once) with protein IDs and spectral counts. Peptide identities are included in the
second tab and ones matching to hits included in Table 1 are highlighted in yellow.
(XLSX)
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S2 Table. Heat map of residues predicted to change PfUCHL3-Ub, -PfNedd8 and
-HsNedd8 binding affinities. The heat map plots the change in binding affinity upon muta-
tion (as the change in the Gibb’s free energy of binding) between PfUCHL3 and Ub (top),
PfNedd8 (middle) and HsNedd8 (bottom). A negative value is predictive of a mutation
expected to disrupt the interaction, whereas a positive value is predictive of a mutation
expected to stabilise the interaction.
(PDF)
S3 Table. Heatmap of PfUCHL3 residues expected to affect Ub and Nedd8 binding affini-
ties differently. To identify mutations in PfUCHL3 predicted to have a different effect upon
Ub and Nedd8 binding, changes in binding affinity upon mutation (as the change in the
Gibb’s free energy of binding) have been calculated as differences between HsNedd8 and Ub
(top) versus PfNedd8 and Ub (bottom). Differences have been expressed as Nedd8 –Ub so that
mutations predicted to affect Nedd8 binding more than Ub binding are negative values (red);
and those predicted to affect Ub binding more than Nedd8 binding are positive (blue).
(PDF)
S1 Fig. T. spiralis UCH37 and C. elegans UCH37 orthologs are DUBs but not deNeddy-
lases. Enzymatic activity of TsUCH37 and CeUBH4 (the UCH37 ortholog) was tested by Ub-
AMC and Nedd8-AMC hydrolysis. A Ub-AMC assay was done using recombinant A)
CeUBH4 or C) TsUCH37. Enzyme at the indicated concentrations was incubated with an
excess of Ub-AMC (250 nM) and hydrolysis was measured in relative fluorescence units. Ned-
d8-AMC hydrolysis by B) CeUBH4 or D) TsUCH37 and its E32D mutant, was measured
using recombinant protein at the indicated concentration incubated with 500 nM of Ned-
d8-AMC. Cleavage was measured by fluorescence output every 15 seconds for a minimum of
30 minutes and as a negative control, enzymes were pre-incubated with NEM for 15 minutes
prior to being used in the assays. Error bars correspond to standard deviation from triplicate
repeats.
(PDF)
S2 Fig. PfUCH37dN retains the ability to hydrolyse Nedd8 and Ubiquitin AMC substrates.
A) Human and P. falciparum UCH37 protein sequences were aligned using MUSCLE. The
polyasparagine repeat in PfUCH37 is highlighted in red and catalytic residues in blue. B) Ub-
AMC Assays were done using recombinant PfUCH37wt and PfUCH37dN proteins. 250nM of
protein was incubated with an excess of Ub-AMC (250 nM) to measure the ability to hydrolyze
Ub-AMC conjugate. PfNedd8-AMC assays were completed using 250nM of recombinant pro-
tein incubated with 250 nM of PfNedd8-AMC. Cleavage was measured by fluorescence output
every 15 seconds for a minimum of 30 minutes. Error bars correspond to standard deviation
from triplicate repeats.
(PDF)
S3 Fig. N13D and D33E mutation do not affect PfUCHL3 deNeddylating activity. Enzy-
matic activity of PfUCHL3 wild type and mutant enzymes was tested by Ub-AMC and Ned-
d8-AMC hydrolysis. Ub-AMC A) and PfNedd8-AMC B) assays were done using recombinant
wild type PfUCHL3, a N13D mutant, a D33E mutant and a double mutant. Enzymes at the
specified concentrations were incubated with an excess of substrate and hydrolysis was mea-
sured in relative fluorescence units every 15 seconds for a minimum of 30 minutes. As a nega-
tive control, wild type enzyme was pre-incubated with NEM for 15 minutes prior to being
used in the assays. Error bars correspond to standard deviation from triplicate repeats.
(PDF)
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S4 Fig. N18D mutation does not uncouple PfUCH37 DUB and deNeddylating activities.
Enzymatic activity of PfUCH37 wild type and N18D mutant enzymes was tested by Ub-AMC
and Nedd8-AMC hydrolysis. A A) Ub-AMC assay and a B) PfNedd8-AMC assay were done
using recombinant PfUCH37 wild type enzyme and a N18D mutant on the same background.
Enzyme at the indicated concentrations was incubated with an excess of Ub-AMC (250 nM)
or Pf-Nedd8-AMC 2.5uM) and clevage was measured by fluorescence output every 15 seconds
for a minimum of 30 minutes and as a negative control, PfUCH37 N18D was pre-incubated
with NEM for 15 minutes prior to being used in the assays. Error bars correspond to standard
deviation from triplicate repeats.
(PDF)
S5 Fig. PfUCHL3 cannot deNeddylate Cullin-1. SCF components (Skp1, Cul1, Myc-Rbx1)
and FLAG-Fbxl17 (wt or ΔFbox) were co-immunoprecipitated out of HEK293T using anti-
FLAG resin and presence of each component was verified by immunoblot (A). The ability of
recombinant HIS-PfUCHL3 and HIS-PfUCH37dN to cleave HsNedd8 off of Cullin-1 was
assessed by anti-Cul1 and anti-Nedd8 immunoblot (B). PfUCHL3 and PfUCH37dN were
detected by anti-HIS and COP9 was probed by anti-CSN5 (the catalytic component of the
COP9 signalosome) immunoblot.
(PDF)
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